In January 2010 Suomen Antidopingtoimikunta, the Finnish Anti-Doping Agency (FINADA), has reported an anti-doping rule violation against the Player after his sample tested positive for the prohibited substances 19-norandrosterone, 19-norandrostenedione and 19-norandrostenediol (metabolites of nandrolone).
FINADA notified the Player and ordered a provisional suspension.
The Player filed a statement in his defence and was heard for the FINADA Supervisory Board.
The Player stated he had used the medication “Deca” (Deca-Durabolin) in order to treat an ankle injury.
On 6 April 2010 the FINADA Supervisory Board decided a two year period of ineligibility starting on the date of the provisional suspension. In July 2010 the Finnish Sports Arbitration Board rejected Player’s appeal. Hereafter FIBA adoptes FINADA’s decision on 24 September 2010.
FIBA 2010 FIBA vs Lon Matthew Gibson
Original document
Parameters
- Legal Source
- Decisions International Federations
- Date
- 6 April 2010
- Arbitrator
- Baumann, Patrick
- Original Source
- International Basketball Federation (FIBA)
- Country
- Finland
- United States of America
- Language
- English
- ADRV
- Adverse Analytical Finding / presence
- Sport/IFs
- Basketball (FIBA) - International Basketball Federation
- Other organisations
- Suomen Antidopingtoimikunta (ADT) - Finnish Anti-Doping Agency (FINADA)
- Doping classes
- S1. Anabolic Agents
- Substances
- 19-norandrostenedione (estr-4-ene-3,17-dione)
- 19-norandrosterone
- Bolandiol (estr-4-ene-3β,17β-diol)
- Nandrolone (19-nortestosterone)
- Medical terms
- Physical injury
- Document type
- Pdf file
- Date generated
- 9 September 2013
- Date of last modification
- 27 February 2014